RadNet's Q4 sales beat estimates, but full-year guidance falls short, causing stock drop.

From Stockstory.org does not belong to any specific media company.: 2025-02-27 17:23:49

RadNet (NASDAQ:RDNT) posted Q4 CY2024 results with revenue up 13.5% to $477.1 million, beating Wall Street estimates. However, full-year revenue guidance of $1.94 billion fell 1.2% below expectations. GAAP profit of $0.07 per share missed estimates by 40.7%. Dr. Howard Berger, CEO, expressed satisfaction with the company’s performance, highlighting revenue and EBITDA growth. RadNet provides outpatient diagnostic imaging services and AI solutions. Sales growth has been strong, with a 9.7% CAGR over five years and 13.5% year-on-year growth in the latest quarter. Operating margin stood at 5.1%. EPS was $0.07 in Q4, below analysts’ forecasts.



Read more at Stockstory.org does not belong to any specific media company.: RadNet’s (NASDAQ:RDNT) Q4 Sales Top Estimates But Stock Drops